Every meaningful advance in treatment has been the result of a clinical trial
The Australian and New Zealand Urogenital and Prostate (ANZUP) Cancer Trials Group mission is to improve treatments and outcomes for people affected by Below the Belt cancers.
Find out more
Poor outcomes from advanced prostate cancer can be reversed with targeted treatment
New research findings of the ENZAMET (ANZUP 1304) study, reveal that people who inherit a genetic biomarker known to predict poorer outcomes with routine prostate cancer treatment, can be successfully treated and have better survival outcomes with personalised hormonal therapy for advanced prostate cancer.
Find Out More
LuPSMA shows promise as first-line treatment for prostate cancer
Lutetium-177 PSMA-617 – or LuPSMA – therapy had been shown in previous clinical trials to extend lives, and improve quality-of-life, in patients with advanced metastatic prostate cancers who have exhausted all other treatment options. The UpFrontPSMA (ANZUP 1904) study was the first to test this treatment in patients with newly diagnosed prostate cancers that had spread.
Find Out More
ANZUP x Sydney Sock Project
That’s right, we have partnered up with the Sydney Sock Project to design and produce a variety of cheeky socks. Say hello to the ‘Penis Sock’ ‘Testicle Sock’ and ‘Below the Belt Sock’.
Grab a Pair
Previous slide
Next slide
0
Trials
0 +

Sites

0 +

Patients Enrolled

0

Countries

ANZUP Cancer, ANZUP

What we do

ANZUP is the leading cancer cooperative clinical trials group that brings together all of the professional disciplines and groups involved in researching and treating below the belt (penile, bladder, kidney, prostate and testicular) cancers and conduct high quality clinical research.

ANZUP identifies gaps in evidence and areas of clinical need, collaborates with the leading clinicians and researchers in below the belt cancers, and communicate frequently and effectively with the broader community along the way.
ANZUP Cancer, ANZUP

Join ANZUP

If you are not yet an ANZUP member then join our large
multidisciplinary network of urogenital and prostate cancer
researchers, clinicians, nurses, psychologists, scientists, allied
health and consumer representatives. Membership is free.

If you are a member of the community and would like to learn more about below the belt cancers, then join ‘Friends of ANZUP’.

ANZUP Cancer, ANZUP

Trials and Research

All of the major milestones in controlling cancer worldwide have
come through clinical trials, but we still have a long way to go to
help every person affected, at risk or diagnosed with this disease.
We have clinical trials across each cancer type, in various stages
of progress: in activation, open to patient recruitment, in follow
up and completed trials.

Telehealth and Teletrials

Teletrials builds on the telehealth model and increases access to clinical trials for people with cancer living in rural and remote locations.

Teleheath and Teletrials

Teletrials builds on the telehealth model and increases access to clinical trials for people with cancer living in rural and remote locations, or in self-isolation due to COVID-19. Teletrials also allows trials recruitment and activity to continue.

Join us to hear from a range of great speakers covering everything from ASM highlights through to exciting updates in the latest clinical trials research.
Check out the program on our website https://anzup.org.au/best-of-gu-oncology-evening-symposium/
Final spots available! Register now!

Healthcare professionals, help us understand how you make treatment decisions for recurrent metastatic prostate cancer. Join our study by completing a quick online questionnaire and participating in an interview or focus group. Sign up or learn more at 🔗https://tinyurl.com/uzfypuhc

Congrats to Study Chair @DrCraigGedye & the team for recruiting their 42nd patient (by site PI @drcbsteer at Border Medical Oncology) on the @ANZUPtrials #ANZadapt trial - reaching 50% recruitment! @Anticancerfund @HMRIAustralia @LUMC_Leiden @CancerAustralia @Prof_IanD

Join us for COTA Conversations. Dr. Blossom Mak to discuss cancer after 50 & early screening. Assoc. Prof. Samantha Oaks PhD, will explore the role of clinical trials in medicine.

Date: Oct 30, 2024
Time: 10:00 - 11:00 am AEST
Via: Zoom

👉 Register: https://ow.ly/2Wok50TQqsM

Load More

Latest News